Reliq Health (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global telemedicine company, is going live with its first clinical trials this month and signs four new contracts in Texas and Florida. When the more than 2,000 new patients are fully onboarded by the end of the calendar year and generating an average revenue of US$60 per patient per month, the company anticipates generating additional gross revenue of more than CDN$150,000 per month.